Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-001831·Adaptive Biotechnologies Corp
Schedule 13G ownership disclosure
ADAPTIVE BIOTECHNOLOGIES CORP
Common stock, par value $0.0001 per share · CUSIP: 00650F109
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sumitomo Mitsui Trust Group, Inc.
Shares: 6,833,137.00 · Class: 4.6%
- Nikko Asset Management Co., Ltd.
Shares: 6,833,137.00 · Class: 4.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-001831
- Form type
- SCHEDULE 13G/A
- Filer
- Adaptive Biotechnologies Corp
- CIK
- CIK 1478320
- Filed
- Feb 04, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership